“I was keen to go on a clinical trial. I wanted to try new cancer treatments and hopefully help future generations.”
A trial looking at anastrozole with or without surgery for older women with breast cancer (ESTEeM)
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
This trial was comparing surgery and anastrozole (Arimidex) with anastrozole alone for breast cancer. It was recruiting women over 75 years old with breast cancer that was
Doctors usually treated older women who have ER positive breast cancer with surgery and hormone therapy or with hormone therapy alone. But there was little research in older women to show who would benefit from having surgery as well as hormone therapy. Surgery has side effects and it is important that older women don’t have operations they don’t need.
In this trial, women had surgery and anastrozole or anastrozole alone. The aims of this study were to find out
- Which treatment was better at controlling the cancer
- More about the side effects and how this affected quality of life
- If other factors, such as age or other illnesses, could help doctors to decide which treatments are best for different women
Summary of results
This trial was never finished so there are no results available. The researchers were unable to recruit enough patients.
How to join a clinical trial
Ms L. Wyld
Mr M. Reed
Cancer Research UK
National Institute for Health Research Cancer Research Network (NCRN)
University of Leeds
University of Sheffield
This is Cancer Research UK trial number CRUK/06/010.